India Hyaluronic Acid Market Size & Outlook, 2026-2033
- Pharmaceuticals
- Active Pharmaceuticals Ingredients & Excipients
- Hyaluronic Acid Market Outlook
- Active Pharmaceuticals Ingredients & Excipients
Global Market
Related Markets
Ask a question about the hyaluronic acid market
India hyaluronic acid market highlights
- The India hyaluronic acid market generated a revenue of USD 229.5 million in 2025 and is expected to reach USD 507.3 million by 2033.
- The India market is expected to grow at a CAGR of 10.4% from 2026 to 2033.
- In terms of segment, dermal fillers was the largest revenue generating application in 2025.
- Dermal Fillers is the most lucrative application segment registering the fastest growth during the forecast period.
Hyaluronic acid market data book summary
| Market revenue in 2025 | USD 229.5 million |
| Market revenue in 2033 | USD 507.3 million |
| Growth rate | 10.4% (CAGR from 2026 to 2033) |
| Largest segment | Dermal fillers |
| Fastest growing segment | Dermal Fillers |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Dermal Fillers, Vesicoureteral Reflux, Osteoarthritis, Ophthalmic |
| Key market players worldwide | Allergan, Sanofi SA, Anika Therapeutics Inc, Bausch Health Companies Inc, Roche Holding AG ADR, Nestle SA, Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Ferring, Lifecore Biomedical Inc, Shiseido Co Ltd, Bloomage BioTechnology, LG Chem, Maruha Nichiro Corp, Genzyme, Seikagaku, HTL Biotechnology |
Other key industry trends
- In terms of revenue, India accounted for 2.0% of the global hyaluronic acid market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China hyaluronic acid market is projected to lead the regional market in terms of revenue in 2033.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 507.3 million by 2033.
The Indian government is taking active steps for decreasing the prevalence of ophthalmic diseases and osteoarthritis. The National Programme for Control of Blindness and Visual Impairment (NPCBVI), a 100% central government-sponsored scheme, was launched by the government to reduce the prevalence of blindness to 0.3% by 2020.
According to Central Bureau of Health Intelligence, a total of 6,690,823 cataract surgeries were performed in India during 2018–2019. High prevalence of diabetes and large number of cataract patients are among factors expected to increase the demand for hyaluronic acid-based eye drops and ophthalmic viscoelastic devices.
According to National Health Portal, osteoarthritis is the second most common rheumatologic problem, and it is the most frequent joint disease with a prevalence of 22% to 39% in India. Moreover, nearly 45% of women aged 65 and above have symptoms of osteoarthritis, while 70% of women aged 65 and above exhibit radiological evidence of osteoarthritis.
No credit card required*
Publish Date: Jun 05, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hyaluronic Acid Market Scope
Hyaluronic Acid Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Sanofi SA | View profile | 87,994 | 46, avenue de la Grande Armée, Paris, France, 75017 | www.sanofi.com |
| Nestle SA | View profile | 270,000 | Avenue Nestle 55, Vevey, Switzerland, CH-1800 | www.nestle.com |
| Zimmer Biomet Holdings Inc | View profile | 18,000 | 345 East Main Street, Warsaw, IN, United States, 46580 | www.zimmerbiomet.com |
| Shiseido Co Ltd | View profile | 35,859 | 5-5 Ginza 7-chome, Chuo-ku, Tokyo, Japan, 104-0061 | www.shiseido.co.jp |
| Allergan | View profile | 10001+ | Madison, Wisconsin, United States, North America | www.allergan.com |
| Smith & Nephew PLC | View profile | 18,452 | Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, United Kingdom, WD18 8YE | www.smith-nephew.com |
| LG Chem | View profile | 10001+ | Seoul, Seoul-t'ukpyolsi, South Korea, Asia | www.lgchem.com |
| Anika Therapeutics Inc | View profile | 357 | 32 Wiggins Avenue, Bedford, MA, United States, 01730 | www.anika.com |
| Ferring | View profile | 5001-10000 | Saint-prex, Vaud, Switzerland, Europe | www.ferring.com |
India Hyaluronic Acid Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Hyaluronic Acid Market Outlook will help companies and investors design strategic landscapes.
Dermal Fillers was the largest segment with a revenue share of 57.04% in 2025.
Horizon Databook has segmented the India hyaluronic acid market based on dermal fillers, vesicoureteral reflux, osteoarthritis, ophthalmic covering the revenue growth of each sub-segment from 2021 to 2033.
The Indian government is taking active steps for decreasing the prevalence of ophthalmic diseases and osteoarthritis. The National Programme for Control of Blindness and Visual Impairment (NPCBVI), a 100% central government-sponsored scheme, was launched by the government to reduce the prevalence of blindness to 0.3% by 2020.
According to Central Bureau of Health Intelligence, a total of 6,690,823 cataract surgeries were performed in India during 2018–2019. High prevalence of diabetes and large number of cataract patients are among factors expected to increase the demand for hyaluronic acid-based eye drops and ophthalmic viscoelastic devices.
According to National Health Portal, osteoarthritis is the second most common rheumatologic problem, and it is the most frequent joint disease with a prevalence of 22% to 39% in India. Moreover, nearly 45% of women aged 65 and above have symptoms of osteoarthritis, while 70% of women aged 65 and above exhibit radiological evidence of osteoarthritis.
- India Hyaluronic Acid Market Application Outlook (Revenue, USD Million , 2021-2033)
- Dermal Fillers
- Osteoarthritis
- Ophthalmic
- Vesicoureteral Reflux
Reasons to subscribe to Hyaluronic Acid Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Hyaluronic Acid Market Outlook databook
- Our clientele includes a mix of Hyaluronic Acid Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India Hyaluronic Acid Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into India Hyaluronic Acid Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
India Hyaluronic Acid Market, 2021-2033 (US$M)
India hyaluronic acid market statistics, by application, 2021-2033 (US$M)
